Correlation of the New York Heart Association Classification and the 6-Minute Walk Distance: A Systematic Review

Clinical Cardiology

Volumn 38, Issue 10, 2015, Pages 621-628

  Yap, Jonathan ^a   Lim, Fang Yi ^b   Gao, Fei ^a,d   Teo, Ling Li ^b   Lam, Carolyn Su Ping ^a,c   Yeo, Khung Keong ^a,d  

^a DEPARTMENT OF CARDIOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; EUROPE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; NORTH AMERICA; PHYSICAL ACTIVITY; POPULATION RESEARCH; REVIEW; WALKING SPEED; AGE; AGED; CLASSIFICATION; EXERCISE TEST; EXERCISE TOLERANCE; HEART FAILURE; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; REPRODUCIBILITY; SEX DIFFERENCE; STATISTICAL MODEL; TIME FACTOR; VERY ELDERLY; WALKING;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SEX FACTORS; TIME FACTORS; WALKING;

EID: 84945477687     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22468     Document Type: Review

References (53)

1. Criteria Committee of the New York Heart Association. Diseases of the heart and blood vessels. In:, Harvey RM, et al, eds. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 7th ed. Boston, MA: Little, Brown & Co.; 1973: 286.
2. Castel MA, Magnani S, Mont L, et al., Survival in New York Heart Association class IV heart failure patients treated with cardiac resynchronization therapy compared with patients on optimal pharmacological treatment. Europace. 2010; 12: 1136-1140.
3. Muntwyler J, Abetel G, Gruner C, et al., One-year mortality among unselected outpatients with heart failure. Eur Heart J. 2002; 23: 1861-1866.
4. Brignole M, Auricchio A, Baron-Esquivias G, et al., 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on Cardiac Pacing and Resynchronization Therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace. 2013; 15: 1070-1118.
5. McMurray JJ, Adamopoulos S, Anker SD, et al., ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC [published correction appears in Eur J Heart Fail. 2013;15:361-362]. Eur J Heart Fail. 2012; 14: 803-869.
6. Goldman L, Hashimoto B, Cook EF, et al., Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation. 1981; 64: 1227-1234.
7. Goode KM, Nabb S, Cleland JG, et al., A comparison of patient and physician-rated New York Heart Association class in a community-based heart failure clinic. J Cardiac Fail. 2008; 14: 379-387.
8. Raphael C, Briscoe C, Davies J, et al., Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart. 2007; 93: 476-482.
9. Fedele F, Severino P, Calcagno S, et al., Heart failure: TNM-like classification. J Am Coll Cardiol. 2014; 63: 1959-1960.
10. Balady GJ, Arena R, Sietsema K, et al., Clinician's guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010; 122: 191-225.
11. Guyatt GH, Sullivan MJ, Thompson PJ, et al., The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J. 1985; 132: 919-923.
12. Lee R, Chan YH, Wong J, et al., The 6-minute walk test predicts clinical outcome in Asian patients with chronic congestive heart failure on contemporary medical therapy: a study of the multiracial population in Singapore. Int J Cardiol. 2007; 119: 168-175.
13. Rostagno C, Olivo G, Comeglio M, et al., Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation. Eur J Heart Fail. 2003; 5: 247-252.
14. Deeks JJ, Altman DG, Bradburn MJ,. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In:, Egger M, Smith GD, Altman DG, eds. Systematic Reviews in Health Care: Meta-analysis in Context. London, UK: BMJ Publishing Group; 2001: 285-312.
15. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7: 177-188.
16. Severo M, Gaio R, Lourenço P, et al., Indirect calibration between clinical observers-application to the New York Heart Association functional classification system. BMC Res Notes. 2011; 4: 276.
17. Castel MA, Méndez F, Tamborero D, et al., Six-minute walking test predicts long-term cardiac death in patients who received cardiac resynchronization therapy. Europace. 2009; 11: 338-342.
18. Alahdab MT, Mansour IN, Napan S, et al., Six minute walk test predicts long-term all-cause mortality and heart failure rehospitalization in African-American patients hospitalized with acute decompensated heart failure. J Cardiac Fail. 2009; 15: 130-135.
19. Shah MR, Hasselblad V, Georghiade M, et al., Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol. 2001; 88: 987-993.
20. Forman DE, Fleg JL, Kitzman DW, et al., 6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure. J Am Coll Cardiol. 2012; 60: 2653-2661.
21. Zugck C, Krüger C, Dürr S, et al., Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? Eur Heart J. 2000; 21: 540-549.
22. Epstein AE, Dimarco JP, Ellenbogen KA, et al., ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary [published correction appears in Heart Rhythm. 2009;6:e1]. Heart Rhythm. 2008; 5: 934-955.
23. Epstein AE, DiMarco JP, Ellenbogen KA, et al., 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013; 61: e6-e75.
24. Radke KJ, King KB, Blair ML, et al., Hormonal responses to the 6-minute walk test in women and men with coronary heart disease: a pilot study. Heart Lung. 2005; 34: 126-135.
25. Gary RA, Sueta CA, Dougherty M, et al., Home-based exercise improves functional performance and quality of life in women with diastolic heart failure. Heart Lung. 2004; 33: 210-218.
26. Ingle L, Cleland JG, Clark AL,. Perception of symptoms is out of proportion to cardiac pathology in patients with "diastolic heart failure." Heart. 2008; 94: 748-753.
27. Boşnak Guçlu M, Inal ̄nce D, Aritkan H, et al., A comparison of pulmonary function, peripheral and respiratory muscle strength and functional capacity in the heart failure patients with different functional classes [article in Turkish]. Anadolu Kardiyol Derg. 2011; 11: 101-106.
28. Karavidas A, Parissis JT, Matzaraki V, et al., Functional electrical stimulation is more effective in severe symptomatic heart failure patients and improves their adherence to rehabilitation programs. J Cardiac Fail. 2010; 16: 244-249.
29. Jankowska EA, Wegrzynowska K, Superlak M, et al., The 12-week progressive quadriceps resistance training improves muscle strength, exercise capacity and quality of life in patients with stable chronic heart failure. Int J Cardiol. 2008; 130: 36-43.
30. Ates I, Yavuz AH, Doʇru M, et al., Effects of ivabradine on 6-minute walk test and quality of life in patients with previously implanted CRT-D. J Investig Med. 2013; 61: 1013-1017.
31. Keast ML, Slovinec D'Angelo ME, Nelson CR, et al., Randomized trial of Nordic walking in patients with moderate to severe heart failure. Can J Cardiol. 2013; 29: 1470-1476.
32. Pepera GK, Sandercock GR, Sloan R, et al., Influence of step length on 6-minute walk test performance in patients with chronic heart failure. Physiotherapy. 2012; 98: 325-329.
33. Zaidi AN, White L, Holt R, et al., Correlation of serum biomarkers in adults with single ventricles with strain and strain rate using 2D speckle tracking. Congenit Heart Dis. 2013; 8: 255-265.
34. Jessup M, Greenberg B, Mancini D, et al., Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2 + -ATPase in patients with advanced heart failure. Circulation. 2011; 124: 304-313.
35. Leszek P, Klisiewicz A, Janas J, et al., Usefulness of 6-minute walk test, plasma neurohumoral and cytokine activation in the assessment of symptomatic patients with left ventricle dysfunction caused by chronic severe mitral valve regurgitation. Acta Cardiol. 2010; 65: 43-51.
36. Jehn M, Schmidt-Trucksäss A, Schuster T, et al., Accelerometer-based quantification of 6-minute walk test performance in patients with chronic heart failure: applicability in telemedicine. J Cardiac Fail. 2009; 15: 334-340.
37. Goscinska-Bis K, Bis J, Krejca M, et al., Totally epicardial cardiac resynchronization therapy system implantation in patients with heart failure undergoing CABG. Eur J Heart Fail. 2008; 10: 498-506.
38. Miller LW, Pagani FD, Russell SD, et al,; HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007; 357: 885-896.
39. Freimark D, Shechter M, Schwamenthal E, et al., Improved exercise tolerance and cardiac function in severe chronic heart failure patients undergoing a supervised exercise program. Int J Cardiol. 2007; 116: 309-314.
40. Román A, Gispert P, Monforte V, et al., Long-term outcomes of treatment with bosentan in pulmonary hypertension [article in Spanish]. Arch Bronconeumol. 2006; 42: 616-620.
41. Torre-Amione G, Sestier F, Radovancevic B, et al., Broad modulation of tissue responses (immune activation) by celacade may favorably influence pathologic processes associated with heart failure progression. Am J Cardiol. 2005; 95: 30C-40C.
42. Ince H, Petzsch M, Rehders TC, et al., Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction. J Endovasc Ther. 2004; 11: 695-704.
43. Guimãraes GV, Bellotti G, Bacal F, et al., Can the cardiopulmonary 6-minute walk test reproduce the usual activities of patients with heart failure? [article in English, Portuguese]. Arq Bras Cardiol. 2002; 78: 553-560.
44. Iellamo F, Volterrani M, Caminiti G, et al., Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. J Am Coll Cardiol. 2010; 56: 1310-1316.
45. Rostagno C, Galanti G, Comeglio M, et al., Comparison of different methods of functional evaluation in patients with chronic heart failure. Eur J Heart Fail. 2000; 2: 273-280.
46. Rostagno C, Galanti G, Felici M, et al., Prognostic value of baroreflex sensitivity assessed by phase IV of Valsalva manoeuvre in patients with mild-to-moderate heart failure. Eur J Heart Fail. 2000; 2: 41-45.
47. Faggiano P, D'Aloia A, Gualeni A, et al., Assessment of oxygen uptake during the 6-minute walking test in patients with heart failure: preliminary experience with a portable device. Am Heart J. 1997; 134 (2 part 1): 203-206.
48. Bagur R, Rodés-Cabau J, Dumont E, et al., Performance-based functional assessment of patients undergoing transcatheter aortic valve implantation. Am Heart J. 2011; 161: 726-734.
49. Tay EL, Papaphylactou M, Diller GP, et al., Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy. Int J Cardiol. 2011; 149: 372-376.
50. Jehn M, Schmidt-Trucksäss A, Schuster T, et al., Pedometer accuracy in patients with chronic heart failure. Int J Sports Med. 2010; 31: 186-191.
51. Vrtovec B, Poglajen G, Lezaic L, et al., Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy. Circulation. 2013; 128 (11 suppl 1): S42-S49.
52. Deuschle K, Weinert K, Becker MO, et al., Six-minute walk distance as a marker for disability and complaints in patients with systemic sclerosis. Clin Exp Rheumatol. 2011; 29 (2 suppl 65): S53-S59.
53. Souza R, Jardim C, Julio Cesar Fernandes C, et al., NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypertension. Respir Med. 2007; 101: 69-75.